-
1تقرير
المؤلفون: Ortakoylu MG; Department of Pulmonary Medicine, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences Turkey, Istanbul 34020, Turkey., Kibar Akilli I; Department of Pulmonary Disease, Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences Turkey, Istanbul 34149, Turkey., Kilic L; Department of Pulmonary Medicine, Koç University Hospital, Koç University, Istanbul 34010, Turkey., Akbaba Bagci B; Department of Pulmonary Medicine, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences Turkey, Istanbul 34020, Turkey., Akalin ES; Department of Pulmonary Medicine, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences Turkey, Istanbul 34020, Turkey., Aksan AD; Department of Pulmonary Medicine, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences Turkey, Istanbul 34020, Turkey., Toprak S; Department of Microbiology, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences Turkey, Istanbul 34020, Turkey., Mirsaeidi M; School of Medicine, University of Florida, Jacksonville, FL 32611, USA.
المصدر: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2023 Jan 27; Vol. 59 (2). Date of Electronic Publication: 2023 Jan 27.
نوع المنشور: Case Reports
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE
مواضيع طبية MeSH: Tuberculosis* , Tuberculosis, Multidrug-Resistant*/drug therapy , Mycobacterium tuberculosis*, Humans ; Antitubercular Agents/therapeutic use ; Isoniazid/pharmacology ; Isoniazid/therapeutic use ; Retrospective Studies ; Pyrazinamide/pharmacology ; Pyrazinamide/therapeutic use ; Fluoroquinolones/pharmacology ; Fluoroquinolones/therapeutic use
-
2دورية أكاديمية
المؤلفون: Korucu E; Yedikule Chest Diseases and Surgery Education and Research Hospital, Istanbul. korucuercan@hotmail.com., Pur Ozyigit L, Ortakoylu MG, Bahadir A, Akalin ES, Kara A, Uzun H, Onal B, Caglar E
المصدر: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG [Sarcoidosis Vasc Diffuse Lung Dis] 2015 Sep 14; Vol. 32 (3), pp. 222-7. Date of Electronic Publication: 2015 Sep 14.
نوع المنشور: Comparative Study; Journal Article
بيانات الدورية: Publisher: Mattioli 1885 Country of Publication: Italy NLM ID: 9610928 Publication Model: Electronic Cited Medium: Internet ISSN: 2532-179X (Electronic) Linking ISSN: 11240490 NLM ISO Abbreviation: Sarcoidosis Vasc Diffuse Lung Dis Subsets: MEDLINE
مواضيع طبية MeSH: Antimicrobial Cationic Peptides/*blood , Sarcoidosis, Pulmonary/*blood , Tuberculosis, Pulmonary/*blood, Adolescent ; Adult ; Aged ; Biomarkers/blood ; Case-Control Studies ; Cross-Sectional Studies ; Diagnosis, Differential ; Down-Regulation ; Female ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prospective Studies ; Sarcoidosis, Pulmonary/diagnosis ; Tuberculosis, Pulmonary/diagnosis ; Vitamin D/analogs & derivatives ; Vitamin D/blood ; Vitamin D Deficiency/blood ; Vitamin D Deficiency/diagnosis ; Young Adult ; Cathelicidins